logo-loader
viewRyah Medtech Inc

RYAH Medtech submits application to list on the Canadian Securities Exchange

The listing is in conjunction with its reverse takeover of Prime Blockchain Inc, which was announced in June 2019

bay street
RYAH and PotBotics CEO Gregory Wagner said that the submission represents a significant milestone

PotBotics Inc, which operates as RYAH Medtech, is planning a listing on the Canadian Securities Exchange, the company announced Monday. 

The listing is in conjunction with its reverse takeover of Prime Blockchain Inc, which was announced in June 2019. 

New York-based RYAH, a wholly-owned subsidiary of PotBotics, focuses on predictive analytics in the global medical plant intake sector. 

READ: RYAH Medtech’s dose-measuring inhaler passes milestone safety test

Its RYAH MediTech business produces a signature vaporizer that can precisely track dose and temperature and pairs with an app that uses artificial intelligence to help patients identify what treatments work best for them.

The submission of the listing statement will kick off a consulting phase by the CSE, with the company to prepare for a subsequent listing on the exchange.

RYAH and PotBotics CEO Gregory Wagner said that the submission represents a significant milestone for RYAH and its planned business combination with Prime.

“We’re grateful for the support that we’ve received throughout the process, and we’re excited to move towards our goal as a public company within a venue that attracts growth capital from investors, enabling RYAH to continue towards its goal of being a leader in clinical and healthcare data analytics,” Wagner said in a statement.

The company recently revealed that its dose-measuring dry herb inhaler passed key medical device compliance tests, clearing a path towards commercialization.

Contact Angela at [email protected]

Follow her on Twitter @AHarmantas

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Ryah Medtech Inc named herein, including the promotion by the Company of Ryah Medtech Inc in any Content on the Site, the Company receives from...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

RYAH Medtech stocks the shelves with its cannabis vaporizer at Maryland...

RYAH Medtech Inc Head of Marketing and Communications Sofiya Kleschuk and Director of Product Operations Jordan Medley join Maryland Sweetspot Dispensary Manager Peter Franklin to tell Proactive Investors the two have joined forces to begin offering RYAH vaporizers to medical...

on 07/11/2019

2 min read